Dr Leila Fourie

Loading player...
DR LEILA FOURIE, JSE CEO.•
On 14 – 15 November, the JSE flew to New York with Public Enterprises Minister, Pravin Gordhan and some SA companies - UBS, Standard Bank and Old Mutual, for the 7th Annual South Africa Tomorrow Investor Conference. The purpose of the conference is to build a strong investor case for South Africa with US investors.

•According to the World Federation of Exchanges, the JSE is performing better than most emerging markets. The value of trade on all global stock exchanges dropped 18% last year while the JSE fared marginally better as it recorded a 13% fall.

•Last week President Cyril Ramaphosa hosted the Investment and Job Summit conference in SA where R363 billion was pledged. And South Africa is currently hosting the Africa Investment Forum where government hopes to expand the investments into the rest of Africa. Then we end the week with a conference where SA government and private sector are standing as one at the JSE SA Tomorrow Investment Conference in New York.

•Both South African listed companies seeking foreign capital and the government will engage on SA growth opportunities with several bankers in New York in a bid to increase the pledges made to invest into the country.
21 Nov 2019 5AM English South Africa Business News · Investing

Other recent episodes

BofA Slashes SA Growth Forecast as Inflation Surges

Bank of America has cut South Africa’s 2026 GDP growth forecast to 1.3%, warning that higher oil and fertilizer prices will keep inflation above 4% for most of the year. Economist Tatonga Rusike explains
23 Apr 3PM 11 min

Understanding SA’s First Wealth Score

Franc unveils South Africa’s first-ever Wealth Score, revealing that financial habits—not income—are the strongest predictor of financial health. We unpack why SA’s national score is 45/100 and the behavior gap between knowing and doing with Dr. Thomas Brennan, founder and CEO of Franc.
23 Apr 3PM 13 min

Clicks Lifts HEPS 8% Despite Warehouse Disruptions.

Clicks delivered firm interim results with diluted HEPS up 8.1%, even as warehouse system delays cost an estimated R175 million in lost sales. CEO Bertina Engelbrecht discusses pharmacy growth, trading margins, and festive‑season competition.
23 Apr 2PM 16 min